Krka Banned from Selling Esomeprazole in Austria
Novo Mesto, 8 November - The Commercial Court in Vienna has issued a temporary injunction banning the Austrian subsidiary of Slovenian pharma company Krka from selling any product that contains the active ingredient esomeprazole with optical purity of more than 99.8%.
The rest of this news item is available to subscribers.
The news item consists of 292 characters (without spaces) or 55 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.